Sleep Monitoring
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
PhilipsNetherlands - Amsterdam
1 programAn Evaluation of Actigraphy as an Indicator of Sleep and Wake in ChildrenN/A1 trial
Active Trials
Oregon TherapeuticsFrance - Paris
1 programAn Evaluation of Actigraphy as an Indicator of Sleep and Wake in ChildrenN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UNEEG Medicalear-EEG
PhilipsAn Evaluation of Actigraphy as an Indicator of Sleep and Wake in Children
Clinical Trials (2)
Total enrollment: 68 patients across 2 trials
Evaluation of the Ear-EEG System for Sleep Monitoring in Healthy Subjects
Start: Mar 2018Est. completion: Nov 202020 patients
N/ACompleted
An Evaluation of Actigraphy as an Indicator of Sleep and Wake in Children
Start: Jun 2009Est. completion: Jun 201348 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.